Paradigm Biocapital Advisors LP
CIK 1855655 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $5.3B
- Posisi
- 28
- Per tanggal
- 30 Juni 2026
#769 dari 9.443 berdasarkan nilai 13F · top 8.1%
Nilai portofolio QoQ: +9.1% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 75,21%
- Bobot 25 kepemilikan teratas
- 99,01%
- Posisi di atas 1%
- 19
- Jumlah posisi efektif
- 10,5
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 23,12% Perkiraan pembelian $1.183.069.073 · penjualan $1.691.186.654
Kepemilikan median: 3,0 kuartal Dilacak Q4 2024–Q2 2026 · 39,4% masih dipegang
- Posisi baru
- 7
- Meningkat
- 12
- Menurun
- 7
- Tertutup
- 14
Di halaman ini
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Rincian sektor
Healthcare
99,6%
Lainnya/Tidak terpetakan
0,4%
Portofolio lengkap 28 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. - Common Stock | $1.191.348.571 | 22,31% | 6.361.323 | $544.081.454 | Turun ×1 | ||
| NUVL Nuvalent, Inc. - Class A Common Stock | $731.667.476 | 13,70% | 5.924.433 | $186.179.315 | Naik ×2 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $415.053.937 | 7,77% | 10.215.455 | $183.055.240 | Naik ×5 | ||
| GMAB Genmab A/S - American Depositary Shares | $360.767.109 | 6,76% | 13.133.131 | $146.990.069 | Naik ×3 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $340.984.271 | 6,38% | 3.840.778 | $242.259.774 | Naik ×2 | ||
| APGE Apogee Therapeutics, Inc. - Common Stock | $209.233.581 | 3,92% | 1.576.385 | $95.751.968 | Naik ×2 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $204.094.539 | 3,82% | 2.144.526 | $90.283.039 | Turun ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $198.736.169 | 3,72% | 6.357.523 | $114.853.684 | Naik ×1 | ||
| BLTE Belite Bio, Inc - American Depositary Shares | $189.844.565 | 3,55% | 1.232.877 | $12.103.404 | Naik ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $174.956.000 | 3,28% | 9.550.000 | $6.802.082 | Turun ×2 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $174.699.348 | 3,27% | 2.775.649 | $-5.035.755 | Naik ×1 | ||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $144.494.400 | 2,71% | 480.000 | Naik ×1 | |||
| INSM Insmed Incorporated - Common Stock | $141.375.668 | 2,65% | 1.325.977 | $-63.758.210 | Naik ×1 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $138.442.428 | 2,59% | 2.508.015 | Naik ×1 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $123.692.037 | 2,32% | 2.127.852 | $-154.830.355 | Turun ×1 | ||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $123.515.986 | 2,31% | 6.723.788 | $61.923.639 | Naik ×2 | ||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $108.468.906 | 2,03% | 8.670.576 | $-11.117.882 | Naik ×5 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $63.491.539 | 1,19% | 2.857.405 | Naik ×1 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $58.405.708 | 1,09% | 1.828.607 | $-20.300.447 | Turun ×1 | ||
| ASMB Assembly Biosciences, Inc. - Common Stock | $42.696.995 | 0,80% | 1.553.748 | $24.236.280 | Naik ×1 | ||
| EYPT EyePoint, Inc. - Common Stock | $41.332.677 | 0,77% | 2.890.397 | $826.664 | Turun ×2 | ||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $32.335.620 | 0,61% | 4.951.856 | Naik ×1 | |||
| VOR Vor Biopharma Inc. - Common Stock | $32.217.500 | 0,60% | 1.750.000 | $997.500 | |||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $24.580.936 | 0,46% | 685.852 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 485925101) | $21.465.000 | 0,40% | 900.000 | Naik ×1 | |||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $19.436.403 | 0,36% | 4.175.382 | $-16.060.526 | Turun ×1 | ||
| EDIT Editas Medicine, Inc. - Common Stock | $18.100.665 | 0,34% | 5.586.625 | Naik ×1 | |||
| IVA Inventiva S.A. - American Depository Shares | $15.120.000 | 0,28% | 4.000.000 | $-7.080.000 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ALNY | $144.494.400 | 480.000 | 2,71% |
| MBX | $138.442.428 | 2.508.015 | 2,59% |
| JBIO | $63.491.539 | 2.857.405 | 1,19% |
| ACHV | $32.335.620 | 4.951.856 | 0,61% |
| MPLT | $24.580.936 | 685.852 | 0,46% |
| Penerbit tidak dikenal (CUSIP: 485925101) | $21.465.000 | 900.000 | 0,40% |
| EDIT | $18.100.665 | 5.586.625 | 0,34% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Dipangkas | -294K | +$544.1M |
| SYRE | Beli lebih banyak | +1.9M | +$242.3M |
| NUVL | Beli lebih banyak | +600K | +$186.2M |
| EWTX | Beli lebih banyak | +2.9M | +$183.1M |
| PCVX | Dipangkas | -2.7M | -$154.8M |
| GMAB | Beli lebih banyak | +5.2M | +$147.0M |
| TNGX | Beli lebih banyak | +2.3M | +$114.9M |
| APGE | Beli lebih banyak | +228K | +$95.8M |
| ORKA | Dipangkas | -176K | +$90.3M |
| INSM | Beli lebih banyak | +71K | -$63.8M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| ACLX | 30 Juni 2026 | 5.774.016 | $662.972.517 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 4.673.770 | $440.035.446 | Tidak lagi dilacak |
| XBI | 31 Maret 2026 | 1.500.000 | $182.895.000 | Tidak lagi dilacak |
| CDTX | 31 Maret 2026 | 759.565 | $167.780.313 | Tidak lagi dilacak |
| CNTA | 30 Juni 2026 | 3.574.048 | $141.961.187 | Tidak lagi dilacak |
| TERN | 30 Juni 2026 | 2.216.499 | $116.853.827 | Tidak lagi dilacak |
| AGIO | 31 Des. 2025 | 2.873.555 | $115.344.498 | 24,1% |
| CRNX | 31 Maret 2026 | 2.210.774 | $102.911.530 | 133,3% |
| CYTK | 30 Juni 2026 | 1.480.857 | $97.603.285 | -9,1% |
| ABVX | 30 Juni 2026 | 772.473 | $86.014.869 | -10,4% |
| ONC | 30 Sep. 2025 | 347.787 | $84.188.799 | 10,4% |
| MAZE | 30 Juni 2026 | 2.744.399 | $81.920.310 | -2,6% |
| JANX | 31 Des. 2025 | 2.920.258 | $71.371.106 | 27,4% |
| VERA | 31 Maret 2025 | 1.437.339 | $60.785.066 | 31,8% |
| SRRK | 30 Juni 2026 | 1.226.080 | $60.274.093 | 0,2% |
| MIRM | 30 Juni 2026 | 625.000 | $57.737.500 | -16,8% |
| BBIO | 31 Maret 2026 | 684.277 | $52.340.348 | 11,3% |
| ALKS | 31 Des. 2025 | 1.719.334 | $51.580.020 | 71,8% |
| LENZ | 31 Des. 2025 | 1.073.461 | $50.001.813 | -70,1% |
| PHVS | 31 Des. 2025 | 1.835.494 | $45.795.575 | 31,2% |
| COGT | 31 Des. 2025 | 3.156.398 | $45.325.875 | 1,8% |
| PLRX | 31 Maret 2025 | 3.197.050 | $42.105.149 | -17,0% |
| MLTX | 30 Sep. 2025 | 878.323 | $41.456.846 | 121,2% |
| OCUL | 31 Maret 2026 | 2.935.284 | $35.634.348 | 33,1% |
| ARGX | 30 Juni 2025 | 59.679 | $35.321.911 | 88,0% |
| CYTK | 30 Juni 2025 | 858.664 | $34.509.706 | 134,5% |
| INSM | 30 Juni 2025 | 451.359 | $34.434.178 | 24,6% |
| MANE | 30 Juni 2026 | 525.000 | $33.153.750 | -14,8% |
| MTSR | 30 Juni 2025 | 1.191.462 | $32.431.596 | Tidak lagi dilacak |
| URGN | 30 Juni 2026 | 1.703.949 | $30.637.003 | 25,7% |
| GPCR | 30 Juni 2026 | 545.287 | $26.282.833 | -5,3% |
| TNGX | 31 Des. 2025 | 3.086.184 | $25.923.946 | 171,3% |
| AMLX | 31 Des. 2025 | 1.900.000 | $25.821.000 | 236,3% |
| DYN | 31 Des. 2025 | 1.898.950 | $24.021.718 | 34,9% |
| ARQT | 30 Juni 2025 | 1.465.334 | $22.917.824 | 79,2% |
| TECX | 31 Maret 2025 | 485.105 | $22.397.298 | 113,0% |
| ORIC | 30 Juni 2026 | 1.701.217 | $21.554.419 | 29,6% |
| YMAB | 30 Sep. 2025 | 4.236.346 | $19.105.920 | Tidak lagi dilacak |
| SRRK | 31 Maret 2025 | 400.000 | $17.288.000 | 71,4% |
| IMTX | 30 Sep. 2025 | 3.144.157 | $16.915.565 | 3,4% |
| IRON | 31 Des. 2025 | 247.716 | $16.369.073 | -1,4% |
| ORKA | 31 Maret 2025 | 819.660 | $15.893.207 | 942,3% |
| GPCR | 31 Des. 2025 | 372.869 | $10.440.332 | -26,9% |
| CBIO | 30 Sep. 2025 | 642.721 | $10.373.517 | 37,0% |
| AGIO | 31 Maret 2025 | 276.439 | $9.083.786 | 15,3% |
| BBOT | 30 Juni 2026 | 868.213 | $7.770.506 | 22,0% |
| KLRS | 30 Juni 2026 | 700.000 | $4.039.000 | 0,7% |